Central Laboratory Biomarker Service Human Immune Inflammatory Cell Drug Action Services
Aeirtec provides preclinical compound testing design conduct with Lead select, profiling and immunogenicity
Aeirtec's immune-inflammatory cellular pharmacology will examine your
compound action in cells from our healthy and diseased subjects; primary or cell lines:
Lymphocytes (naïve and memory)
Dendritic Cells
Macrophages
Osteoclasts
Monocytes
Neutrophils
Platelets
Synoviocytes
Chondrocytes

Human Immune and inflammatory cells provide you with the best cellular predictor of compound action in the clinic. Human cells can be applied to examination of compound efficacy, vaccine potential or immunogenicity (automated fluorescence ELISPOT)

To discuss your preclinical requirements - email: info@aeirtec.co.uk